2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Transcatheter aortic-valve replacement in low-risk patients at five years

MJ Mack, MB Leon, VH Thourani… - … England Journal of …, 2023 - Mass Medical Soc
Background A previous analysis in this trial showed that among patients with severe,
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …

Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus

HC Herrmann, R Mehran, DJ Blackman… - … England Journal of …, 2024 - Mass Medical Soc
Background Patients with severe aortic stenosis and a small aortic annulus are at risk for
impaired valvular hemodynamic performance and associated adverse cardiovascular …

Signaling pathways and therapeutic interventions in gastric cancer

ZN Lei, QX Teng, Q Tian, W Chen, Y **e… - Signal transduction and …, 2022 - nature.com
Gastric cancer (GC) ranks fifth in global cancer diagnosis and fourth in cancer-related death.
Despite tremendous progress in diagnosis and therapeutic strategies and significant …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure

H Tsutsui, T Ide, H Ito, Y Kihara, K Kinugawa… - Circulation …, 2021 - jstage.jst.go.jp
After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and …

HI Michelena, A Della Corte… - European Journal of …, 2021 - academic.oup.com
Abstract This International Consensus Classification and Nomenclature for the congenital
bicuspid aortic valve condition recognizes 3 types of bicuspid valves: 1. The fused type (right …

Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR

NM Van Mieghem, M Unverdorben… - … England Journal of …, 2021 - Mass Medical Soc
Background The role of direct oral anticoagulants as compared with vitamin K antagonists
for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not …

Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk

MB Leon, MJ Mack, RT Hahn, VH Thourani… - Journal of the American …, 2021 - jacc.org
Background In low surgical risk patients with symptomatic severe aortic stenosis, the
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …